Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 33Brain Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 17Lung Neoplasms 15Carcinoma, Hepatocellular 13Breast Neoplasms 10Pancreatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Neoplasms 6Colorectal Neoplasms 6Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Spinal Cord Neoplasms 3Small Cell Lung Carcinoma 3Prostate Cancer Metastatic 3Nasopharyngeal Carcinoma 3Kidney Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Sarcoma 2Radiation Injuries 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroma, Acoustic 2Neoplasms by Site 2Klatskin Tumor 2Head and Neck Neoplasms 2

Interventions

Radiotherapy 3Nivolumab 3pembrolizumab 2Temozolomide 2Surveys and Questionnaires 2Paclitaxel 2ONC206 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Etoposide 2Cyclophosphamide 2Carboplatin 2Biopsy 2regorafenib 1pegfilgrastim 1mirdametinib 1lutetium Lu 177 dotatate 1fludarabine 1etoposide phosphate 1entrectinib 1entinostat 1elacestrant 1decitabine and cedazuridine drug combination 1cabozantinib 1amino-acid, glucose, and electrolyte solution 1alectinib 1aflibercept 1abemaciclib 1Topotecan 1Tissue Banks 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Central Nervous System Neoplasms × Radiosurgery × Clear all
NCT04977375 2025-09-03

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
10 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡